LIFEVANTAGE CORP Variable Lease, Cost
LIFEVANTAGE CORP (LFVN) reported Variable Lease, Cost of $119.00 thousand for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-08-27
- LIFEVANTAGE CORP variable lease, cost for the quarter ending 2026-06-30 was $22.00K, a 38.89% decline year-over-year.
- LIFEVANTAGE CORP variable lease, cost for the quarter ending 2026-03-31 was $29.00K, a 34.09% decline year-over-year.
- LIFEVANTAGE CORP variable lease, cost for the quarter ending 2025-12-31 was $34.00K, a 3.03% increase year-over-year.
- LIFEVANTAGE CORP variable lease, cost for the quarter ending 2025-09-30 was $35.00K, a 14.63% decline year-over-year.
- LIFEVANTAGE CORP variable lease, cost for fiscal 2026 was $119.00K, a 22.73% decline from fiscal 2025.
- LIFEVANTAGE CORP variable lease, cost for fiscal 2025 was $154.00K, a 11.49% decline from fiscal 2024.
- LIFEVANTAGE CORP variable lease, cost for fiscal 2024 was $174.00K, a 38.52% decline from fiscal 2023.
- LIFEVANTAGE CORP variable lease, cost for fiscal 2023 was $283.00K, a 6.39% increase from fiscal 2022.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2026-06-30 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $51.00K derived: sum of 2 quarters · filed 2026-08-27 | $85.00K derived: sum of 3 quarters · filed 2026-08-27 | $119.00K 10-K · filed 2026-08-27 |
| 2026-03-31 | $29.00K 10-Q · filed 2026-05-06 | $63.00K derived: sum of 2 quarters · filed 2026-05-06 | $97.00K 10-Q · filed 2026-05-06 | $134.00K derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-12-31 | $34.00K 10-Q · filed 2026-02-04 | $68.00K 10-Q · filed 2026-02-04 | $105.00K derived: sum of 3 quarters · filed 2026-08-27 | $149.00K derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-09-30 | $35.00K 10-Q · filed 2025-11-04 | $71.00K derived: sum of 2 quarters · filed 2026-08-27 | $115.00K derived: sum of 3 quarters · filed 2026-08-27 | $148.00K derived: sum of 4 quarters · filed 2026-08-27 |
| 2025-06-30 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $80.00K derived: sum of 2 quarters · filed 2026-08-27 | $113.00K derived: sum of 3 quarters · filed 2026-08-27 | $154.00K 10-K · filed 2026-08-27 |
| 2025-03-31 | $44.00K 10-Q · filed 2026-05-06 | $77.00K derived: sum of 2 quarters · filed 2026-05-06 | $118.00K 10-Q · filed 2026-05-06 | $156.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $33.00K 10-Q · filed 2026-02-04 | $74.00K 10-Q · filed 2026-02-04 | $112.00K derived: sum of 3 quarters · filed 2026-02-04 | $154.00K derived: sum of 4 quarters · filed 2026-02-04 |
| 2024-09-30 | $41.00K 10-Q · filed 2025-11-04 | $79.00K derived: sum of 2 quarters · filed 2025-11-04 | $121.00K derived: sum of 3 quarters · filed 2025-11-04 | $166.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $38.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-04 | $80.00K derived: sum of 2 quarters · filed 2025-09-04 | $125.00K derived: sum of 3 quarters · filed 2025-09-04 | $174.00K 10-K · filed 2025-09-04 |
| 2024-03-31 | $42.00K 10-Q · filed 2025-05-06 | $87.00K derived: sum of 2 quarters · filed 2025-05-06 | $136.00K 10-Q · filed 2025-05-06 | $229.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $45.00K 10-Q · filed 2025-02-05 | $94.00K 10-Q · filed 2025-02-05 | $187.00K derived: sum of 3 quarters · filed 2025-02-05 | $290.00K derived: sum of 4 quarters · filed 2025-02-05 |
| 2023-09-30 | $48.00K 10-Q · filed 2024-10-29 | $142.00K derived: sum of 2 quarters · filed 2024-10-29 | $245.00K derived: sum of 3 quarters · filed 2024-10-29 | $303.00K derived: sum of 4 quarters · filed 2024-10-29 |
| 2023-06-30 | $94.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-28 | $197.00K derived: sum of 2 quarters · filed 2024-08-28 | $255.00K derived: sum of 3 quarters · filed 2024-08-28 | $283.00K 10-K · filed 2024-08-28 |
| 2023-03-31 | $103.00K 10-Q · filed 2024-05-02 | $161.00K derived: sum of 2 quarters · filed 2024-05-02 | $189.00K 10-Q · filed 2024-05-02 | |
| 2022-12-31 | $58.00K 10-Q · filed 2024-01-30 | $85.00K 10-Q · filed 2024-01-30 | ||
| 2022-09-30 | $27.00K 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | $266.00K 10-K · filed 2023-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |